Having trouble accessing articles? Reset your cache.

MK-6913: Development discontinued

Merck discontinued development of MK-6913 to treat hot flashes after interim data from the first stage of a double-blind,

Read the full 198 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE